Final Answer:
The compounded capsules would be classified as Schedule V controlled substances due to the presence of codeine, which is a narcotic analgesic.
Explanation:
In the United States, the Controlled Substances Act (CSA) classifies drugs based on their potential for abuse, safety, and medical use. Codeine, a narcotic analgesic, is classified as a Schedule V controlled substance under the CSA. Schedule V drugs have lower potential for abuse compared to Schedule I-IV drugs and are generally used for medical purposes.
In this case, we have mixed 300mg of codeine powder with 3250mg of acetaminophen (APAP) to prepare 10 capsules that contain 355mg of the compounded mixture each. The compounded mixture contains a total of 300mg of codeine per capsule, which is less than the maximum recommended dose of 600mg per day for adults. This suggests that the compounded mixture has a lower potential for abuse compared to pure codeine preparations.
Furthermore, acetaminophen is a non-narcotic analgesic and antipyretic that is commonly used to treat pain and fever. It is not classified as a controlled substance under the CSA because it has a low potential for abuse and is generally considered safe when used as directed.
Based on these factors, the compounded capsules containing codeine and APAP would be classified as Schedule V controlled substances due to the presence of codeine. This classification reflects the lower potential for abuse associated with the compounded mixture compared to pure codeine preparations.